myMatrixx Rated #1 PBM by the Workers' Comp Industry
myMatrixx has built a reputation as a class-leading PBM by committing to the fundamentals of trust and expertise and keeping an overriding focus on patient safety and driving down drug costs. This reputation is consistently backed up by independent data. As just the latest example, myMatrixx has received the highest PBM ranking in a recently published survey by consulting group CompPharma.
CompPharma is an independent service providing valuable insights to both payers and PBMs across the industry. The firm’s annual Prescription Drug Management in Workers’ Compensation Survey Report gathers the perceptions and thoughts of payers on managing prescription drug programs. The goal of the survey is to gain insight on the major cost drivers, management approaches, problems and trends that decision makers are facing — and how they are working to control costs and meet clinical goals.
According to the 2021 report, workers’ compensation payers are balancing their focus on core drug management issues, including:
- The ongoing opioid crisis
- Physician dispensing
- The impact of COVID-19
Of the seven workers’ compensation PBMs ranked by the 28 survey respondents, myMatrixx received the highest rating in the 2021 survey.
- myMatrixx has now received the number one ranking in the industry since CompPharma began rating PBMs in 2019
- This year, myMatrixx received a score of 3.7, out-scoring the number two PBM by nearly a half a point
- The scores were based on respondents’ perception of the PBMs based on reputation and firsthand experience
The 2021 report combines data from 2019 and 2020 after a pause last year due to the COVID-19 pandemic.